Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes

Key-interventions derived from three evidence based guidelines for management and follow-up of patients with HFE haemochromatosis

(2016) Annick Vanclooster et al.   BMC HEALTH SERVICES RESEARCH

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics

(2016) Sarah S. Kalia et al.   GENETICS IN MEDICINE

A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation

(2016) Jessica Ezzell Hunter et al.   GENETICS IN MEDICINE

Clinical Genomics

(2016) Arjun K. Manrai et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia

(2016) Barbara de Graaff et al.   Applied Health Economics and Health Policy

Clinical Manifestations of Hemochromatosis inHFEC282Y Homozygotes Identified by Screening

(2016) Gordon D McLaren et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

The promise and peril of genomic screening in the general population

(2015) Michael C. Adams et al.   GENETICS IN MEDICINE

Economic evaluation of genetic screening for Lynch syndrome in Germany

(2015) Franziska Severin et al.   GENETICS IN MEDICINE

The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates

(2015) Scott D. Grosse et al.   GENETICS IN MEDICINE

Natural history ofHFEsimple heterozygosity for C282Y and H63D: A prospective 12-year study

(2015) Sophie G Zaloumis et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)

(2015) Sim Yee Ong et al.   BMJ Open

A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome

(2014) Tristan Snowsill et al.   HEALTH TECHNOLOGY ASSESSMENT

Hereditary Hemochromatosis: Time for Targeted Screening

(2013) Pradyumna D. Phatak et al.   ANNALS OF INTERNAL MEDICINE

Recommendations for returning genomic incidental findings? We need to talk!

(2013) Wylie Burke et al.   GENETICS IN MEDICINE

Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies

(2013) Katrina A.B. Goddard et al.   GENETICS IN MEDICINE

Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium

(2013) Jonathan S. Berg et al.   GENETICS IN MEDICINE

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

(2013) Robert C. Green et al.   GENETICS IN MEDICINE

Cancer risk inHFEC282Y homozygotes: results from the HUNT 2 study

(2013) ARNE Åsberg et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network

(2012) Stephanie M. Fullerton et al.   GENETICS IN MEDICINE

Re: "The Emergence of Translational Epidemiology: From Scientific Discovery to Population Health Impact"

(2011) A. Morabia   AMERICAN JOURNAL OF EPIDEMIOLOGY

Neighborhood Environment and Physical Activity Among Youth

(2011) Ding Ding et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome

(2011) Valérie Bonadona   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

How I treat hemochromatosis

(2010) P. C. Adams et al.   BLOOD

The Southern French registry of genetic hemochromatosis: a tool for determining clinical prevalence of the disorder and genotype penetrance

(2010) P. Aguilar-Martinez et al.   HAEMATOLOGICA

HFECys282Tyr homozygotes with serum ferritin concentrations below 1000 μg/L are at low risk of hemochromatosis

(2010) Katrina J. Allen et al.   HEPATOLOGY

The Natural History of Untreated HFE-Related Hemochromatosis

(2009) Paul C. Adams   ACTA HAEMATOLOGICA

HFE C282Y Homozygosity Is Associated With Lower Total and Low-Density Lipoprotein Cholesterol

(2009) Paul C. Adams et al.   Circulation-Cardiovascular Genetics

HFE-associated hereditary hemochromatosis

(2009) Jacob Alexander et al.   GENETICS IN MEDICINE

Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives

(2009)   GENETICS IN MEDICINE

The Cost-Effectiveness of Screening for Hereditary Hemochromatosis in Germany: A Remodeling Study

(2009) Wolf H. Rogowski   MEDICAL DECISION MAKING

Population Screening for Genetic Disorders in the 21st Century: Evidence, Economics, and Ethics

(2009) S.D. Grosse et al.   Public Health Genomics

Response: Screening for treatable disease is better than just screening for hemochromatosis

(2008) J. Waalen et al.   BLOOD

Iron-Overload–Related Disease inHFEHereditary Hemochromatosis

(2008) Katrina J. Allen et al.   NEW ENGLAND JOURNAL OF MEDICINE

HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study

(2008) James S. Pankow et al.   Translational Research

Clinical penetrance of C282Y homozygousHFEhemochromatosis

(2008) Enrico Rossi et al.   Expert Review of Hematology